Pronađeno: 1-7 / 7 radova

Autori: Lentz SR

>> Filter: Samo Article i Review

Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas  Janic Dragana M  Ozelo M  Santagostino E  Korsholm Lars  Matytsina Irina  Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter)
Autori Lentz SR  Cerqueira MH  Janic Dragana M  Kempton CL  Matytsina Irina  Misgav M  Oldenburg J  Ozelo M  Recht M  Rosholm A  Savic Aleksandar D  Suzuki Takashi  Tiede Andreas  Santagostino E 
Info HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR  Kempton CL  Janic Dragana M  Savic Aleksandar D  Cerqueira MH  Ozelo MC  Recht M  Oldenburg J  Tiede Andreas  Suzuki Takashi  Matytsina Irina  Zeuthen N  Santagostino E 
Info JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2015), vol. 13 br. , Suppl. 2, str. 842-842
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials (Article)
Autori Santagostino E  Lentz SR  Misgav M  Brand B  Chowdary Pratima  Savic Aleksandar D  Kilinc Yurdanur  Amit Y  Amendola A  Solimeno LP  Saugstrup T  Matytsina Irina 
Info HAEMOPHILIA, (2015), vol. 21 br. 1, str. 34-40
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article)
Autori Lentz SR  Misgav M  Ozelo MC  Salek SZ  Veljkovic Dobrila K  Recht M  Cerqueira MH  Tiede Andreas  Brand B  Mancuso ME  Seremetis S  Lindblom A  Martinowitz U 
Info HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian (TM) Trials (Meeting Abstract)
Autori Santagostino Elena  Lentz SR  Misgav M  Brand B  Chowdary Pratima  Savic Aleksandar D  Kilinc Yurdanur  Tuddenham Edward GD  Lindblom A 
Info BLOOD, (2012), vol. 120 br. 21, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A (Meeting Abstract)
Autori Lentz SR  Misgav M  Ozelo MC  Zupancic-Salek Silva  Veljkovic Dobrila K  Recht M  Cerqueira MH  Tiede Andreas  Brand B  Mancuso ME  Martinowitz U 
Info HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-830
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX